Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel Trial

Noel W Clarke, Andrew J Armstrong, Mototsugu Oya,Neal Shore,Giuseppe Procopio, João Daniel Guedes,Cagatay Arslan,Niven Mehra,Francis Parnis,Emma Brown,Friederike Schlürmann,Jae Young Joung,Mikio Sugimoto,Oliver Sartor,Christian Poehlein, David McGuinness, Arnold Degboe,Fred Saad

European urology oncology（2024）

引用 0|浏览7

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要